Peter Vestergaard: Clinical Trials

1 trial sponsored by Peter Vestergaard, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Peter Vestergaard: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
Cinacalcet 30 mg Tablet, Denosumab Inj 60 mg/ml, Placebo tablets - Primary Hyperparathyroidism, Parathyroid Adenoma
Phase 3CompletedPeter Vestergaard462017-03-012021-05-25

Conditions studied

Hyperparathyroidism, Primary (1)  ·  Parathyroid Neoplasms (1)

Interventions

Cinacalcet (1)  ·  Denosumab (1)  ·  Sodium Chloride (1)  ·  Tablets (1)

Countries

Denmark (1)

Top investigators

Julius Simoni Leere, MD (1)

Results publications

PMID 32333877

NIH funding

2016 (1)